Angel Matthew 4
4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Aug 3, 2022
Insider Transaction Report
Form 4
Angel Matthew
DirectorInterim President and CEO
Transactions
- Award
Stock Option (right to buy)
2022-08-01+2,487,003→ 2,487,003 totalExercise: $0.49Exp: 2032-08-01→ Common Stock, par value $0.005 per share (2,487,003 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable over four years (subject to continued service), with 2/48th of the shares vesting on the grant date and the remaining shares vesting in 46 substantially equal monthly installments thereafter.